Influenza Vaccination Effectiveness for People Aged Under 65 years in Japan, 2013/2014 Season: Application of a Doubly Robust Method to a Large-scale, Real-world Dataset

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2019 Jul 7

PMID 31277580

Citations 4

Authors

Natsumi Shibata

Shinya Kimura

Takahiro Hoshino

Hisashi Urushihara

Affiliations

Soon will be listed here.

Abstract

Background: Influenza vaccination is recognized as a primary public health intervention which prevents the illness of patients and relieves the societal burdens of influenza for medical community as well as the economy. To date, no effectiveness study of influenza vaccination has been conducted including a large population with a wide age span, in Japan. Here, we evaluated the clinical effectiveness of influenza vaccination in a large Japanese population.

Methods: We conducted a cohort study using a large-scale claims database for employee health care insurance plans. Vaccination status was identified using plan records for influenza vaccination subsidies. We excluded people aged 65 years or more because of the unavailability of vaccination records. Effectiveness of vaccination in preventing influenza and its complication was evaluated with doubly robust methods using inversed probability treatment weighting to adjust health conscious behaviours and other confounders.

Results: During the 2013/2014 influenza season, 369,425 subjects with age range from 1 to 64 years were eligible. Vaccination rate was 39.5% and an estimated odds ratio (OR) for influenza onset was 0.775 after doubly robust adjustment. Age-stratified ORs were significantly reduced in all age groups; lowest in subjects aged 1 to 4 years (0.600) and highest in those aged 13 to 19 (0.938). ORs for all the influenza complication outcomes were also statistically significant (0.403-0.709).

Conclusions: We confirmed the clinical effectiveness of influenza vaccination in people aged 1 to 64 years. Influenza vaccination significantly prevented influenza onset and was more effective in reducing secondary risks of influenza complications.

Citing Articles

Comparison of the incidence of bleeding between baloxavir marboxil and other anti-influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment-based health insurance claims database in Japan.

Hara A, Hara K, Komeda T, Ogura E, Miyazawa S, Kobayashi C Pharmacoepidemiol Drug Saf. 2021; 31(6):623-631.

PMID: 34881477 PMC: 9303239. DOI: 10.1002/pds.5392.

Characterization and selection of Japanese electronic health record databases used as data sources for non-interventional observational studies.

Wakabayashi Y, Eitoku M, Suganuma N BMC Med Inform Decis Mak. 2021; 21(1):167.

PMID: 34022876 PMC: 8140583. DOI: 10.1186/s12911-021-01526-6.

Data resource profile: JMDC claims database sourced from health insurance societies.

Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T J Gen Fam Med. 2021; 22(3):118-127.

PMID: 33977008 PMC: 8090843. DOI: 10.1002/jgf2.422.

Correction to: Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/ 2014 season: application of a doubly robust method to a large-scale, real-world dataset.

Shibata N, Kimura S, Hoshino T, Urushihara H BMC Infect Dis. 2019; 19(1):709.

PMID: 31405366 PMC: 6691521. DOI: 10.1186/s12879-019-4286-7.

References

Reichert T, Sugaya N, Fedson D, Glezen W, Simonsen L, Tashiro M . The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001; 344(12):889-96. DOI: 10.1056/NEJM200103223441204. View

Jackson L, Jackson M, Nelson J, Neuzil K, Weiss N . Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2005; 35(2):337-44. DOI: 10.1093/ije/dyi274. View

Orenstein E, De Serres G, Haber M, Shay D, Bridges C, Gargiullo P . Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007; 36(3):623-31. DOI: 10.1093/ije/dym021. View

Molinari N, Ortega-Sanchez I, Messonnier M, Thompson W, Wortley P, Weintraub E . The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25(27):5086-96. DOI: 10.1016/j.vaccine.2007.03.046. View

Suissa S . Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2007; 167(4):492-9. DOI: 10.1093/aje/kwm324. View

Nichol K . Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine. 2009; 27(45):6305-11. DOI: 10.1016/j.vaccine.2009.07.006. View

Baxter R, Lee J, Fireman B . Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis. 2009; 201(2):186-9. DOI: 10.1086/649568. View

Kimura S, Sato T, Ikeda S, Noda M, Nakayama T . Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010; 20(5):413-9. PMC: 3900837. DOI: 10.2188/jea.je20090066. View

Campitelli M, Rosella L, Stukel T, Kwong J . Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine. 2010; 29(2):240-6. DOI: 10.1016/j.vaccine.2010.10.049. View

10.

Shrank W, Patrick A, Brookhart M . Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011; 26(5):546-50. PMC: 3077477. DOI: 10.1007/s11606-010-1609-1. View

11.

Funk M, Westreich D, Wiesen C, Sturmer T, Brookhart M, Davidian M . Doubly robust estimation of causal effects. Am J Epidemiol. 2011; 173(7):761-7. PMC: 3070495. DOI: 10.1093/aje/kwq439. View

12.

Chartrand C, Leeflang M, Minion J, Brewer T, Pai M . Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012; 156(7):500-11. DOI: 10.7326/0003-4819-156-7-201204030-00403. View

13.

Sturmer T, Wyss R, Glynn R, Brookhart M . Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014; 275(6):570-80. PMC: 4037382. DOI: 10.1111/joim.12197. View

14.

Sugaya N . A review of the indirect protection of younger children and the elderly through a mass influenza vaccination program in Japan. Expert Rev Vaccines. 2014; 13(12):1563-70. DOI: 10.1586/14760584.2014.951036. View

15.

Song J, Lee J, Wie S, Kim H, Lee J, Seo Y . Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol. 2014; 22(2):229-34. PMC: 4308868. DOI: 10.1128/CVI.00673-14. View

16.

Brown C, McCaw J, Fairmaid E, Brown L, Leder K, Sinclair M . Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children. Influenza Other Respir Viruses. 2015; 9(5):247-54. PMC: 4548994. DOI: 10.1111/irv.12331. View

17.

Cheng A, Kotsimbos T, Kelly P . Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014. Vaccine. 2015; 33(51):7352-7356. DOI: 10.1016/j.vaccine.2015.10.016. View

18.

Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M . Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. J Infect Dis. 2016; 213(10):1546-56. PMC: 4837903. DOI: 10.1093/infdis/jiv577. View

19.

Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S . Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill. 2016; 21(38). PMC: 5073201. DOI: 10.2807/1560-7917.ES.2016.21.38.30348. View

20.

Matias G, Haguinet F, Lustig R, Edelman L, Chowell G, Taylor R . Model estimates of the burden of outpatient visits attributable to influenza in the United States. BMC Infect Dis. 2016; 16(1):641. PMC: 5100308. DOI: 10.1186/s12879-016-1939-7. View